Aim & Scope
Transplantation Proceedings and Research (ISSN: 2836-8991) is an international, Open Access publisher of peer-reviewed journals encompassing a broad spectrum of scientific research and technological disciplines.
Transplantation Proceedings and Research (ISSN: 2836-8991) is originated with a rigid commitment of serving the scientific and research community by inviting innovations and a vision to encourage the existing scientists, experts and young scientists to enlighten the common society, encompassing a broad spectrum of scientific research and technological disciplines.
Transplantation Proceedings and Research (ISSN: 2836-8991) is an Open Access single blinded peer-reviewed medical journal, publish original research articles, review papers, clinical studies, case reports, editorials, and perspectives etc. It seeks support from individuals, institutes, libraries, universities, funding agencies, and others.
Transplantation Proceedings and Research (ISSN: 2836-8991) focuses on organ transplant disorders, post-transplant complications, immunological responses, graft rejection, and related clinical interventions.
The current research in Transplantation Proceedings and Research (ISSN: 2836-8991) involves the development of new techniques to minimize these ailments and provides knowledge for researchers, practitioners, and even common people.
Transplantation Proceedings and Research (ISSN: 2836-8991) accepts the articles in the fields of organ transplantation, Tissue Transplantation, Immunosuppression, Transplant Immunology, Graft Survival, Rejection (Acute & Chronic), Donor Matching, Xenotransplantation, Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation, Corneal Transplantation, Bone Marrow Transplantation, Vascularized Composite Allograft, HLA Matching, Allograft vs. Xenograft, Tolerance Induction, Immune Monitoring, T-Cell Mediated Rejection, Antibody-Mediated Rejection, Biomarkers for Rejection, Immunosuppressive Drugs, Organ Donation Ethics, Living Donor Transplantation, Deceased Donor Allocation, Presumed Consent Laws, Organ Trafficking, Brain Death Criteria, Regenerative Medicine, Stem Cell Transplantation, Gene Editing in Transplantation, Machine Perfusion Technology, Artificial Organs, 3D Bioprinting of Organs.
Authors can contribute their valuable submission through online and/or to info@mediresonline.org
Organ Transplantation: Organ transplantation is a medical procedure in which a diseased or failing organ is surgically removed from a donor and replaced with a healthy organ from a compatible donor. It aims to restore the normal function of the affected organ and improve the recipient’s quality of life.
Tissue Transplantation: Tissue Transplantation is the process of transferring cells, tissues, or organs from a donor to a recipient to restore function or replace damaged biological structures. It can involve autografts (self), allografts (same species), or xenografts (different species) and requires careful matching to prevent immune rejection.
Immunosuppression: Immunosuppression is the reduction or inhibition of the immune system’s ability to fight infections and diseases. It can be caused by medications, diseases, or medical treatments, leading to increased susceptibility to infections and impaired immune responses.
Transplant Immunology: Transplant immunology is the branch of immunology that studies the immune system’s response to transplanted organs, tissues, or cells. It focuses on mechanisms of graft acceptance, rejection, and strategies to prevent immune-mediated transplant failure.
Graft Survival: Graft Survival refers to the continued viability and proper function of a transplanted tissue or organ in the recipient’s body over time. It indicates that the graft has not been rejected and maintains its intended physiological role.
Rejection (Acute & Chronic): Rejection is the immune-mediated response of a recipient’s body against a transplanted organ or tissue. Acute rejection occurs days to weeks post-transplant, characterized by rapid immune attack, while chronic rejection develops over months to years, leading to gradual organ dysfunction and fibrosis.
Donor Matching: Donor matching is the process of identifying a compatible donor for organ, tissue, or stem cell transplantation by comparing blood type, human leukocyte antigens (HLA), and other immunological factors to minimize the risk of rejection and ensure transplant success. It ensures optimal compatibility between the donor and recipient.
Xenotransplantation: Xenotransplantation is the process of transplanting cells, tissues, or organs from one species to another, most commonly from animals to humans. It aims to address the shortage of human organs for transplantation but carries risks of immune rejection and cross-species disease transmission.
Kidney Transplantation: Kidney Transplantation is a surgical procedure in which a healthy kidney from a living or deceased donor is implanted into a patient with end-stage renal disease or kidney failure. It restores kidney function, improving waste removal, fluid balance, and overall health.
Liver Transplantation: Liver Transplantation is a surgical procedure in which a diseased or failing liver is replaced with a healthy liver from a living or deceased donor. It is performed to restore liver function in patients with end-stage liver disease, acute liver failure, or certain liver cancers. The procedure involves removing the damaged liver and implanting the donor liver, followed by lifelong immunosuppressive therapy to prevent rejection.
